ARCHIVES

Study Tests PARP Inhibitor ABT-888 For Several Cancers

This article is from The Cancer Letter archive.

Vol. 32 No. 9 | September 25, 2009

Download PDF Visit The Full Archive

Related Articles

Wilding named director, Univ. of Wisconsin Cancer Center.

January 30, 2004

Moloney Out As Viral Oncology Chief, Names “Acting Assistant Director” Of NCI By Upton

January 6, 1978

NCI Bypass Budget Calls For $5.98 Billion

December 6, 2002

Letrozole Combination Increases PFS In ER+ and HER2-Negative Breast Cancer

January 25, 2013

White Heads NIH Legislative Policy Office

March 5, 2010

SWOG Wins Funding For H. Pylori Trial.

November 21, 2008